Global Trimethylhydroquinone Market (2022 to 2027) – Growing Active Pharmaceutical Ingredient (API) Industry Presents Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Trimethylhydroquinone Market (2022-2027) by Application, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The Global Trimethylhydroquinone Market is estimated to be USD 981.85 Mn in 2022 and is projected to reach USD 1185.41 Mn by 2027, growing at a CAGR of 3.84%. … [Read more…]

Wellbeing Subsidiary KGK Science Enters into Research Contract With Nova Mentis for Phase II A Clinical Trial

KGK to conduct Phase II clinical trial to test the efficacy of psilocybin on Fragile X syndrome VANCOUVER, British Columbia–(BUSINESS WIRE)–$KONEF #psychedelics–Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital … [Read more…]

Grant Avenue Capital Launches Helios Clinical Research

New Integrated Clinical Site Organization Led by World-Class Clinical Development Experts Provides Greater and More Equitable Access to High-Quality Research NEW YORK–(BUSINESS WIRE)–Grant Avenue Capital, LLC (“Grant Avenue”), a middle market healthcare-focused private equity firm, today announced the launch of Helios Clinical Research (“Helios”), a new integrated clinical site organization that partners with patients, physicians, … [Read more…]

Organigram and InterCure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies

Organigram to supply Israeli pharmaceutical grade cannabis leader InterCure with up to 20,000 kg of dried flower over multiple years TORONTO & HERZILA, Israel–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), ( “Organigram”) a leading Canadian licensed producer of cannabis and Canndoc Ltd. (“Canndoc”), a subsidiary of InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) … [Read more…]

Marinus Pharmaceuticals Announces Collaboration with Tenacia Biotechnology for Ganaxolone Development and Commercialization in China

Collaboration leverages Tenacia’s CNS, R&D, and local market expertise to support expansion of ganaxolone’s development programs and potentially provide additional access to patients globally Marinus to receive an upfront fee of $10 million and eligible to receive up to $256 million in development, regulatory and commercialization milestone payments, as well as tiered low double-digit royalties … [Read more…]

Research Published in Melanoma Management Finds that 99% of Patients with Uveal Melanoma Tested with DecisionDx®-UM Gain Value from the Results

There was no significant difference in decision regret levels among those receiving a low- (Class 1A), intermediate- (Class 1B) or high-risk (Class 2) DecisionDx-UM test result FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #CSTL–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publication of a study completed in collaboration … [Read more…]

With 70% of Toronto Residents Concerned They Will Get Sick at Work, BreatheEasyTO Measures the Indoor Air Safety of 100+ Public Spaces

Results from the first city-wide testing of businesses to evaluate the risk of flu, RSV, and COVID-19 transmission show that people experience a wide range of ventilation safety over the course of a day TORONTO–(BUSINESS WIRE)–#BreatheEasy–According to a Leger survey of workers in the Greater Toronto Area (GTA) conducted on behalf of BreatheEasy, 70% are … [Read more…]

The Worldwide Hemophilia Treatment Industry is Projected to Reach $26.9 Billion by 2031 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Hemophilia Treatment Market By Type, By Drug Therapy: Global Opportunity Analysis and Industry Forecast, 2021-2031” report has been added to ResearchAndMarkets.com’s offering. The global hemophilia treatment market was valued at $12,764.8 million in 2021, and is projected to reach $26,905.2 million by 2031, registering a CAGR of 7.5% from 2022 to 2031. Hemophilia … [Read more…]

Global Collagen Market Report 2022: Rising Demand for Collagen in the Food & Beverage and Pharmaceutical Industries to Drive Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Collagen Market by Product Type (Gelatin, Hydrolyzed Collagen, and Native Collagen), Source (Bovine, Porcine, and Marine & Poultry), Application (Nutritional Products, Food & Beverages, and Pharmaceuticals), Form and Region – Global Forecast to 2026” report has been added to ResearchAndMarkets.com’s offering. The collagen market is estimated to be valued at USD 4.1 billion … [Read more…]

Outlook on the Endoluminal Suturing Devices Global Market to 2028 – Featuring Apollo Endosurgery, Medtronic, Cook Medical and Suture Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Endoluminal Suturing Devices Market Size, Share & Industry Trends Analysis Report By Application (Gastrointestinal Surgery, Bariatric Surgery, Gastroesophageal Reflux Disease Surgery and Others), By End User, By Regional Outlook and Forecast, 2022 – 2028” report has been added to ResearchAndMarkets.com’s offering. The Global Endoluminal Suturing Devices Market size is expected to reach … [Read more…]